Rapamycin eluting stent: the onset of a new era in interventional cardiology

This publication has 10 references indexed in Scilit:

• Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
  European Heart Journal, 2001
• Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
  Circulation, 2001
• Gene Expression Profiling of Human Stent-Induced Neointima by cDNA Array Analysis of Microscopic Specimens Retrieved by Helix Cutter Atherectomy
  Circulation, 2001
• Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries
  Circulation, 2001
• Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell Cycle
  Circulation, 1999
• Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
  1997
• Rapamycin inhibits vascular smooth muscle cell migration.
  Journal of Clinical Investigation, 1996
• Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
  Circulation Research, 1995
• TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENT
  Transplantation, 1995
• RAPAMYCIN INHIBITS ARTERIAL INTIMAL THICKENING CAUSED BY BOTH ALLOIMMUNE AND MECHANICAL INJURY
  Transplantation, 1993